“Bottle Of Lies Exposes The Dark Side Of The Generic-Drug Boom” – re-emphasized the book, released in May 2019. This confirms, the raging debate on the questionable quality of many generic drugs manufactured in India and involving several top domestic pharma companies, … Continue reading
Tag Archives: US-FDA
In a Quandary of Drug Quality, Price Control, Innovation and Patient Interest in India
The patients in India have every reason to apprehend, whether the prescription drugs that they consume are efficacious, safe and conform to the government approved prices, alongside another important question: Do they affordable access to the fruits of innovation? The … Continue reading
The Takeover Magician To Tango Again On A Bold New ‘Sunny’ Tune
The consolidation process of the Indian pharmaceutical industry continues in its own pace. Most recently, the homegrown pharma takeover magician is all set to tango yet again with a bold ‘Sunny’ tune. The low profile creator of high value ‘Sun … Continue reading
Just Born A Pharma Goliath: Would India Be Impacted?
Just born a potential pharma Goliath, as Actavis – the Dublin-based one of the largest global generic drug makers, in its biggest ever purchase, acquires New York based R&D based pharma major – Forest Laboratories, for a whopping US$ 25 billion. … Continue reading